Gilde Healthcare agrees eighth exit of 2014 selling Definiens stake to MedImmune

Netherlands and US-based private equity firm Gilde Healthcare has sealed its eight exit of the year by selling its stake in Definiens to AstraZeneca biologics R&D arm MedImmune.